Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T‐cell period: Preservation of vaccine‐associated antibodies between 0 and 6 months

Documenti analoghi

• InsT‐ALLing CD7 chimeric antigen receptors before transplantation
  di: Julio Delgado
  Pubblicazione: (2024)
• CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia
  di: Fengjiao Han, et al.
  Pubblicazione: (2025)
• Advances and challenges in chimeric antigen receptor‐natural killer cell immunotherapy for cancer
  di: Hind Rafei, et al.
  Pubblicazione: (2024)
• The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies
  di: Helena Brillembourg, et al.
  Pubblicazione: (2024)
• Unveiling the responsible antigen in vaccine‐induced immune thrombotic thrombocytopenia
  di: Chika Edward Uzoigwe
  Pubblicazione: (2025)